Services Markets About Us Resource Center News & Events Careers
Pharmacology Testing Services
Toxicology Testing Services
Bioanalytical Testing Services
Biocompatibility Testing Services
Analytical Testing Services
Specialty Services
Laboratory Services
Pathology
Clinical Pathology
In-Vitro Services
Histology
Surgery Services
Japanese Testing Services
Microbiology Testing Services

In Vitro Services

The in vitro services at Toxikon offer a full range of study with applications to assist customers in the drug development process, drug discovery, IND, Phase I-III trials, and NDA submissions. The in vitro assays provide important information, including metabolism, cytotoxicity, for investigational candidates that is essential for pharmaceutical product development. All studies are conducted in compliance with GLP regulations.

Quality Assurance Unit monitors all aspects of drug metabolism studies, from the development of study specific SOPs, through the conduct of the study, to report, preparation, and finalization.

In Vitro Services Include:

  • Cell Viability (Cytotoxicity)
  • Cell Proliferation Assay
  • Study the species variation in metabolism using cells, both hepatic (e.g. hepatocytes) and extrahepatic (e.g. keratinocytes), and subcellular fractions, such as microsomal and S9 preparations
  • Study drug-drug interactions that may occur due to Cytochrome P450 (CYP450) inhibition or induction
  • Study induction of CYP450 by compounds using CYP-specific assays and Western immunoblotting
  • Metabolite stability, profile, and identification
  • Enzyme and immunoassays such as ELISA, RIA

All the in vitro assays can be performed using compounds/test articles that are both radiolabeled and non-radiolabeled.

Toxikon Excels in Preclinical Ophthalmic Testing and Drug Development
May 31, 2006

Toxikon Corporation announces the availability of services for preclinical testing and development of ophthalmic drugs and devices.